Cargando…

Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate

The aim of this study is to report a patient with corneal opacity that developed after the use of topical antiglaucoma medications other than brimonidine tartrate (BT). An 85-year-old woman presented with corneal opacity and neovascularization in both eyes. A diagnosis of glaucoma was made 20 years...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasuya, Yuka, Sano, Ichiya, Makino, Shinji, Kawashima, Hidetoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273428/ https://www.ncbi.nlm.nih.gov/pubmed/32547800 http://dx.doi.org/10.1155/2020/4803651

Ejemplares similares

Rolling removal technique for a tick embedded in the eyelid
por: Kondo, Yuka, et al.
Publicado: (2022)

Fluorimetric Quantification of Brimonidine Tartrate in Eye Drops
por: Sunitha, G., et al.
Publicado: (2013)

The role of brimonidine tartrate gel in the treatment of rosacea
por: Jackson, J Mark, et al.
Publicado: (2015)

Bilateral Lipid Keratopathy in the Setting of Brimonidine Tartrate Use
por: Moshirfar, Majid, et al.
Publicado: (2023)

The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
por: Alonso, Ruiz Simonato, et al.
Publicado: (2020)

Use of brimonidine tartrate to resolve telangiectatic matting: case report
por: de Mello, Brenno Augusto Seabra, et al.
Publicado: (2020)

Multiple ocular manifestations in a case of cat scratch disease without systemic signs
por: Annoura, Kanako, et al.
Publicado: (2020)

Preparation and Evaluation of Nano-vesicles of Brimonidine Tartrate as an Ocular Drug Delivery System
por: Prabhu, P, et al.
Publicado: (2010)

Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes
por: Abdel Azim, Engy A, et al.
Publicado: (2022)

Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery
por: Xu, Haonan, et al.
Publicado: (2023)

Changes in Corneal Epithelial Thickness Induced by Topical Antiglaucoma Medications
por: Nam, Myungsik, et al.
Publicado: (2021)

Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
por: Dubey, Akhilesh, et al.
Publicado: (2014)

Effects of brimonidine tartrate 0.1% ophthalmic solution on the pupil, refraction, and light reflex
por: Kato, C. O. Sayaka, et al.
Publicado: (2018)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients
por: Tsumura, Toyoaki, et al.
Publicado: (2014)

Antiglaucoma pharmacotherapy
por: Tătaru, CP, et al.
Publicado: (2012)

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
por: Orii, Yusuke, et al.
Publicado: (2023)

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults
por: Nejad, Mitra, et al.
Publicado: (2021)

Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics
por: Yang, Jing, et al.
Publicado: (2023)

Corneal epithelial toxicity of antiglaucoma formulations: in vitro study of repeated applications
por: Meloni, Marisa, et al.
Publicado: (2012)

The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea
por: Johnson, Andrew William, et al.
Publicado: (2015)

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems
por: Sun, Jianguo, et al.
Publicado: (2017)

A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost
por: Krupa, Małgorzata, et al.
Publicado: (2017)

Effects of the Glaucoma Drugs Latanoprost and Brimonidine on Corneal Temperature
por: Konieczka, Katarzyna, et al.
Publicado: (2019)

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study
por: Orii, Yusuke, et al.
Publicado: (2022)

Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells
por: Ayaki, Masahiko, et al.
Publicado: (2010)

The Antiglaucoma Agent and EP2 Receptor Agonist Omidenepag Does Not Affect Eyelash Growth in Mice
por: Esaki, Yoshihiko, et al.
Publicado: (2020)

Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops
por: Azarcon, Corrina P., et al.
Publicado: (2020)

Novel long-acting brimonidine tartrate loaded-PCL/PVP nanofibers for versatile biomedical applications: fabrication, characterization and antimicrobial evaluation
por: Salim, Samar A., et al.
Publicado: (2023)

'Aolan' Treatment in Corneal Ulcer and Corneal Opacity
por: Pandya, D. N.
Publicado: (1931)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
Publicado: (2015)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
Publicado: (2015)

Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
por: Emad Eldeeb, Alaa, et al.
Publicado: (2019)

Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial
por: Kim, Ko Eun, et al.
Publicado: (2023)

Corneal tattooing for esthetic purposes in patients with corneal opacities
por: Doganay, Derya, et al.
Publicado: (2020)

Tartrate of Morphia as an Agent for Hypodermic Injection
por: Stuart, John A. Erskine
Publicado: (1879)

The Effect of Antiglaucoma Procedures (Trabeculectomy vs. Ex-PRESS Glaucoma Drainage Implant) on the Corneal Biomechanical Properties
por: Konstantinidis, Aristeidis, et al.
Publicado: (2021)

Wide Corneal Epithelial Thickness Mapping in Eyes With Topical Antiglaucoma Therapy Using Optical Coherence Tomography
por: Ye, Yiming, et al.
Publicado: (2022)

Cataract surgery in patients with corneal opacities
por: Ho, Yi-Ju, et al.
Publicado: (2018)

Corneal Opacity Following Bell’s Palsy
por: Smith, Philip E M
Publicado: (2000)

Use Pattern of Ophthalmic Antiglaucoma Agents with and without Preservatives: A Cross-Sectional Study
por: Valladales-Restrepo, Luis Fernando, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_000rbnnrs4489g14jnnh5cqnr3